G
Glenn M. Chertow
Researcher at Stanford University
Publications - 830
Citations - 94517
Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.
Papers
More filters
Journal ArticleDOI
#2758 ambient heat exposure and estimated glomerular filtration rate trajectory: a post-hoc analysis of the dapa-ckd trial
Glenn M. Chertow,Ricardo Correa-Rotter,Antonio Gasparrini,N. Verhaest-de Jong,Anna Maria Langkilde,Malcolm Mistry,John J.V. McMurray,Peter Rossing,Robert B. Toto,Priya Vart,Dorothea Nitsch,David A. Wheeler,Ben Caplin +12 more
TL;DR: The DAPA-CKD trial showed that higher ambient heat exposure is associated with a faster loss of kidney function in patients with established, all-cause, chronic kidney disease as discussed by the authors .
Posted ContentDOI
Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022
Meri Varkila,Maria E. Montez-Rath,Joshua A. Salomon,Xue Yu,Geoffrey Block,Douglas K Owens,Glenn M. Chertow,Julie Parsonnet,Shuchi Anand +8 more
TL;DR: In this article , the authors examined the performance of two wastewater metrics in predicting high case and hospitalization rates both before and after widespread use of at-home COVID-19 tests and concluded that the predictive capability of wastewater percentile declined over time (AUC 0.84 and 0.72 for cases for second and third quarters of 2022).
Journal ArticleDOI
Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism.
Charu Gupta,Glenn M. Chertow,Mark T. Linthicum,Karen Van Nuys,Vasily Belozeroff,Darryl L. Quarles,Darius N. Lakdawalla +6 more
TL;DR: The broader Medicare dialysis bundle reimburses providers uniformly, even though patients treated more intensively for sHPT cost more to treat, and this flat payment schedule may encourage providers to avoid high-intensity patients or reduce their treatment intensity.
Journal ArticleDOI
Race and Place in ESKD
TL;DR: The authors focus on Black men, who experience markedly higher rates of ESKD than nonBlack men, particularly at younger ages, and highlight one element of place, the proportion of Black residents, which contributes to rates of death and hospitalization among Black men receiving hemodialysis.
Journal ArticleDOI
Population-Wide Screening for Chronic Kidney Disease
Marika M. Cusick,Rebecca L. Tisdale,Glenn M. Chertow,Douglas K Owens,Jeremy D. Goldhaber-Fiebert +4 more
TL;DR: In this article , a cost-effectiveness analysis of using SGLT2 inhibitors to detect chronic kidney disease (CKD) in adults was conducted in the United States.